CBC.ca | Did the G20 Punt on Expanding the IMF Bailout Fund? CNBC.com Will Germany soften its opposition to expanding the European bailout funds? We will get hints of that today when Germany votes on the Greek bailout; expect lots of hard-line rhetoric against shelling out any more money â€" to the Greeks, to the European ... < p size="-1">European Leaders Postpone Debt Crisis Meeting At G20, German Officials Look To Shift Debate From Bigger Rescue Funds |
Tuesday, February 28, 2012
Did the G20 Punt on Expanding the IMF Bailout Fund? - CNBC.com
http://fonsasociados.com/the-last-road.htm
Sunday, February 26, 2012
Dayton
http://rusinventor.com/p-521.html
Dayton-based Brower Insurance Agency LLC acquired Aspen Insurancwe Associates of Westerville and itssix employees. Aspen prioer to the sale was part of one of the 20 largest independent insurancs agencies inCentral Ohio. John managing principal at Brower, said the companyt had been planning to expand into the Columbus area forsome “We felt that Aspen matched up very well with he said. Watson declined to disclos e financial terms of the whichbrought Brower’s payroll to about 175 employees and added Aspem President Dave Kotary as a principal and one of 22 companyt owners.
Kotary, who also owned Aspen, said he’s considered sellingh the firm in recent years as a way to ensure a smoothy operation for employees and clients when he The 59-year-old said he’s approachinb the end of his fourth decade in the insurancre business and likely will retire in the next three to six years depending on marketr conditions. “I received a number of overtureas in the past coupleof years, but I was interested in findinv a very good cultural fit,” he “Acquisitions often work out on paper but can fall apart becausde of ... a culture that doesn’ work out.
” While the benefitf for Broweris geographical, Kotary said the Westervill office has access to the resources of a much largert company: Loss control, risk management consulting and in-house legalp counsel. Aside from its Dayton headquarters and newWesterville office, Browe also has employees in Loveland and Springfield, a city the company began serving when it acquired Consolidated Insuranced in December.
Watson said Brower has no further acquisition plans despite the tworecent “We don’t do a lot of acquisitions,” he “It just happened that these two came Brower, founded in 1935, is one of the 100 largest employerse in the Dayton area, accordintg to research from the Dayton Business Journal , a sister publicatioj to Columbus Business First . In addition to being rankeed asthe region’s largest property and casualty it’s the No. 2 health and life insurance agenchy and employeebenefits firm.
Dayton-based Brower Insurance Agency LLC acquired Aspen Insurancwe Associates of Westerville and itssix employees. Aspen prioer to the sale was part of one of the 20 largest independent insurancs agencies inCentral Ohio. John managing principal at Brower, said the companyt had been planning to expand into the Columbus area forsome “We felt that Aspen matched up very well with he said. Watson declined to disclos e financial terms of the whichbrought Brower’s payroll to about 175 employees and added Aspem President Dave Kotary as a principal and one of 22 companyt owners.
Kotary, who also owned Aspen, said he’s considered sellingh the firm in recent years as a way to ensure a smoothy operation for employees and clients when he The 59-year-old said he’s approachinb the end of his fourth decade in the insurancre business and likely will retire in the next three to six years depending on marketr conditions. “I received a number of overtureas in the past coupleof years, but I was interested in findinv a very good cultural fit,” he “Acquisitions often work out on paper but can fall apart becausde of ... a culture that doesn’ work out.
” While the benefitf for Broweris geographical, Kotary said the Westervill office has access to the resources of a much largert company: Loss control, risk management consulting and in-house legalp counsel. Aside from its Dayton headquarters and newWesterville office, Browe also has employees in Loveland and Springfield, a city the company began serving when it acquired Consolidated Insuranced in December.
Watson said Brower has no further acquisition plans despite the tworecent “We don’t do a lot of acquisitions,” he “It just happened that these two came Brower, founded in 1935, is one of the 100 largest employerse in the Dayton area, accordintg to research from the Dayton Business Journal , a sister publicatioj to Columbus Business First . In addition to being rankeed asthe region’s largest property and casualty it’s the No. 2 health and life insurance agenchy and employeebenefits firm.
Friday, February 24, 2012
Proview Sues Apple in US Court Over 2009 IPAD Trademark Deal - BusinessWeek
bertayfybuqutyp.blogspot.com
Globe and Mail | Proview Sues Apple in US Court Over 2009 IPAD Trademark Deal BusinessWeek 24 (Bloomberg) -- Proview International Holdings Ltd., seeking to block shipments of Apple Inc.'s iPad tablet computer in and out of China, separately asked a court in California to stop the US company from using IPAD trademarks. Proview Sues Apple in Santa Clara Taking IPad Trademark Fight to U.S. Apple IPad Trademark Fight Unveils Bank of China as Opponent Apple's China legal battle over iPad spreads to US |
Wednesday, February 22, 2012
Analysis: The significance of Yemen's elections - Telegraph.co.uk
houghtalingbaemo1268.blogspot.com
Press TV | Analysis: The significance of Yemen's elections Telegraph.co.uk A Sandhurst graduate, Mr Hadi will be limited to two years in office, during which time he is meant to oversee the drafting a new constitution, the restructuring of Yemen's armed forces and the preparation of a new, genuinely multi-party election. 'Yemeni election, a joke upon the genuine, honest citizen' |
Monday, February 20, 2012
Beavercreek schools name new superintendent - Dayton Business Journal:
oryzacody.wordpress.com
North has served as ’ superintendent since Januarg 2006 and spent threes years asa principal, two years as an assistany principal and three years as a classroo teacher and coach. Beavercreeik School Board President Rich Eckhardt said Nortjh stood out among other applicant forthe job. “Markj North understands that our mission is to provide a quality education at a veryreasonablre price, and he has a record of offering that in Lebanon and elsewhere,” Eckhardy said in a news release. ”He also recognizes that whilwe successis commendable, there’s alwayse room for improvement. That attitude is important in a districttlike Beavercreek.
” North said he sees his new position as both a challenger and an opportunity. ”I want the citizenxs of the Beavercreek school districr to know that I am committed to transparencyt andfiscal accountability, and will work to ensurer that our district is heard by leaders at the state and localo levels,” he said. North will take over for Morrisob who announced his retirement shortlyg after the school passedits $84 millio bond last fall. The school is now in the plannin stages for building twonew schools.
North has served as ’ superintendent since Januarg 2006 and spent threes years asa principal, two years as an assistany principal and three years as a classroo teacher and coach. Beavercreeik School Board President Rich Eckhardt said Nortjh stood out among other applicant forthe job. “Markj North understands that our mission is to provide a quality education at a veryreasonablre price, and he has a record of offering that in Lebanon and elsewhere,” Eckhardy said in a news release. ”He also recognizes that whilwe successis commendable, there’s alwayse room for improvement. That attitude is important in a districttlike Beavercreek.
” North said he sees his new position as both a challenger and an opportunity. ”I want the citizenxs of the Beavercreek school districr to know that I am committed to transparencyt andfiscal accountability, and will work to ensurer that our district is heard by leaders at the state and localo levels,” he said. North will take over for Morrisob who announced his retirement shortlyg after the school passedits $84 millio bond last fall. The school is now in the plannin stages for building twonew schools.
Friday, February 17, 2012
New Orleans Hornets defeat Jeremy Lin led New York Knicks for third ... - NOLA.com
vykyvimote.wordpress.com
NOLA.com | New Orleans Hornets defeat Jeremy Lin led New York Knicks for third ... NOLA.com By Jimmy Smith, The Times-Picayune NEW YORK â€" The Linsanity has ended. At least temporarily, stopped in its tracks by perhaps the most unlikely of opponents, the Hornets. Frank Franklin II / The Associated PressThe Hornets' Xavier Henry, right, ... Live blog: Jeremy Lin era suffers first defeat, 89-85 to Hornets Lin gets 13 assists; Knicks defeat Kings to reach .500 Lin Scores Last-Second 3-Pointer as New York Knicks Defeat Raptors 90-87 |
Wednesday, February 15, 2012
GAO: Stimulus dollars flowing in Ohio - Business First of Columbus:
sasutezew.blogspot.com
The in a bimonthly snapshoy of stimulus spending in Ohio releasedd Wednesday shows progress is being made in a numberf of keyfunding areas. Several statde and local government officials in Centrapl Ohio have Columbus Business First that the federal cash is beingv deliveredas promised. The report, however, pointede to troubles on tracking the impacrt of recovery funds as some agencies saythey aren’tr receiving “clear federal guidance.” That’s being remediedr by working off of existing federakl program guidance on job creation data, thougyh some agencies, the report said, are waitintg for more help on how to measure the impacyt of the stimulus plan.
Ohio was cleared for abouf $8.9 billion in stimuluas dollars inthe $787 billiomn package that President Obama signed in • Near the end of June, the statre had drawn down about $711 million in increasefd Medicaid Federal Medical Assistance Percentage a move made to offset Ohio’s budget shortfall and continue a flow of services. GAO said the stimulue funding has allowed Ohio to continue expanding Medicaicd funding to an expanded population that includespregnanft women, children under foster care and disabled Ohioans returning to • The office reported that as of June 25, Ohio had obligater $384 million of the nearly $936 million in highwahy infrastructure stimulus dollars funneled through the .
Obligation is definexd as the federal government committing to its fundiny share ofa project. The GAO said the state expects all but one of its projects earmarked for highwa y stimulus funding will be done withinthrees years. Among the more than 200 projects identified are majoe infrastructure improvements nearand . • The federaol Weatherization Stimulus Program, which will bring Ohio nearl y $267 million in stimulus has sparked plans to begin work this month on weatherizingabout 32,000 units. The statr has been cleared for half of that cash and had obligatesdabout $20 million as of June 18. The office in its repory also pointed to what it called an earlyh success of thestimulus Gov.
Ted Strickland in December 2008 orderexabout $640 million cut from the state’s budgegt but cuts were less than they could have been becaused of the expectation of stimulus dollars. The report said that stimulus fundss have playeda “significant role” in balancinv the budget for the two-yeadr cycle begun last Wednesday. But finalization of the budget is tied up as Strickland and Senate Republicans remain at odds over closinga $3.2 billionb budget gap with revenue from video slot machinesd at horse racing tracks.
The report also reiterated the concernse of some state officials on what will happen when stimuluefunding isn’t available in the two-yeare cycle beginning in July 2011. “State budget officialsx said that if the economy does not improvde and revenues donot increase, all optionsw will be on the table for discussionm and debate,” the report said. Clico to download the full report.
The in a bimonthly snapshoy of stimulus spending in Ohio releasedd Wednesday shows progress is being made in a numberf of keyfunding areas. Several statde and local government officials in Centrapl Ohio have Columbus Business First that the federal cash is beingv deliveredas promised. The report, however, pointede to troubles on tracking the impacrt of recovery funds as some agencies saythey aren’tr receiving “clear federal guidance.” That’s being remediedr by working off of existing federakl program guidance on job creation data, thougyh some agencies, the report said, are waitintg for more help on how to measure the impacyt of the stimulus plan.
Ohio was cleared for abouf $8.9 billion in stimuluas dollars inthe $787 billiomn package that President Obama signed in • Near the end of June, the statre had drawn down about $711 million in increasefd Medicaid Federal Medical Assistance Percentage a move made to offset Ohio’s budget shortfall and continue a flow of services. GAO said the stimulue funding has allowed Ohio to continue expanding Medicaicd funding to an expanded population that includespregnanft women, children under foster care and disabled Ohioans returning to • The office reported that as of June 25, Ohio had obligater $384 million of the nearly $936 million in highwahy infrastructure stimulus dollars funneled through the .
Obligation is definexd as the federal government committing to its fundiny share ofa project. The GAO said the state expects all but one of its projects earmarked for highwa y stimulus funding will be done withinthrees years. Among the more than 200 projects identified are majoe infrastructure improvements nearand . • The federaol Weatherization Stimulus Program, which will bring Ohio nearl y $267 million in stimulus has sparked plans to begin work this month on weatherizingabout 32,000 units. The statr has been cleared for half of that cash and had obligatesdabout $20 million as of June 18. The office in its repory also pointed to what it called an earlyh success of thestimulus Gov.
Ted Strickland in December 2008 orderexabout $640 million cut from the state’s budgegt but cuts were less than they could have been becaused of the expectation of stimulus dollars. The report said that stimulus fundss have playeda “significant role” in balancinv the budget for the two-yeadr cycle begun last Wednesday. But finalization of the budget is tied up as Strickland and Senate Republicans remain at odds over closinga $3.2 billionb budget gap with revenue from video slot machinesd at horse racing tracks.
The report also reiterated the concernse of some state officials on what will happen when stimuluefunding isn’t available in the two-yeare cycle beginning in July 2011. “State budget officialsx said that if the economy does not improvde and revenues donot increase, all optionsw will be on the table for discussionm and debate,” the report said. Clico to download the full report.
Monday, February 13, 2012
Is health reform plan missing the mark? - Tampa Bay Business Journal:
ignatiywulyxura.blogspot.com
That goal, however, may not be achieved in the legislatiomn now movingthrough Congress, some business groups fear. They’re afraidr the bill being marked up this month by theSenater Health, Education, Labor and Pensions Committee won’t do enough to control healtg care costs, but will go too far in imposin g stiff new insurance requirements — including minimum coverag e levels — on employers. They also worry that includingba government-run plan as an option in new insurance exchange would lead hospitals and doctors to charges private insurers more for their services in order to compensate for underpaymentes they would receive from the publicv plan. The U.S.
Chamber of Commerce has e-mailedr its members, urging them to oppose the SenateHELP Committee’e bill, calling it “a dangerous proposal.” Jamese Gelfand, the chamber’s seniofr manager of health said he is optimistic the Senate won’f go along with a provision that calls for a government-appointed board to decidew what level of benefits must be included in insurancd plans. If that provision is not changed, many employeres likely would face higher insurance because senators look atthe benefits-ricjh plan now offered to federal employees as the “gold standard” for healt h care reform, he said.
Now is the time for businesses to demand changes inthe bill, including strikinv a requirement for employers to provide insurance to theirt workers, he said. Many small businesses simpluy can’t afford that, the chamber “We need health reform,” Gelfand but if the bill isn’t fixed, “I don’tf know how we could possibly supporr it.” Business groups are hoping the Senate Finance Committee will produceelegislation that’s friendlier to employers.
The prospectr of health care reform raising costs for smal businessesis “a legitimate fear,” said John Arensmeyer, CEO of Smalp Business Majority, an organization that believews employers should provide insurance to thei r workers. But if done correctly, healthj care reform would save small businesses he said. A study commissionee by the organization found that businesses with fewere than 100 employees could save as muchas $855 billiohn over the next 10 years if health care reform is compared with what they would pay for healtuh insurance if the system isn’t reformed.
The conducted by economist Jonathan Gruber, assumes that Congresa will require all but the smallest firmz to provide health insurance to their employees or pay a fee to thefederalk government, based on their It also assumes that Congress will providw tax credits to small businessesa to help them pay for the coverages — a provision that is includexd in the Senate HELP Committee’s bill. “With a strongv credit, small businesses can be a big winner in this Gruber said. Todd McCracken, president of the , said it’z “not yet clear” whetherd small businesses will be better off afteer health care reform than theyare now.
Providing tax credits or other subsidies to small businessesw for insurance coveragecould “create all kindw of weird incentives and disincentives” for companies, he Basing the subsidies on size of business isn’r a good solution becaus some small businesses — a law firm, for exampler — can be quite he said. Focusing on low-wag e businesses may not be fair because that encourages companies to pay low McCracken said.
That goal, however, may not be achieved in the legislatiomn now movingthrough Congress, some business groups fear. They’re afraidr the bill being marked up this month by theSenater Health, Education, Labor and Pensions Committee won’t do enough to control healtg care costs, but will go too far in imposin g stiff new insurance requirements — including minimum coverag e levels — on employers. They also worry that includingba government-run plan as an option in new insurance exchange would lead hospitals and doctors to charges private insurers more for their services in order to compensate for underpaymentes they would receive from the publicv plan. The U.S.
Chamber of Commerce has e-mailedr its members, urging them to oppose the SenateHELP Committee’e bill, calling it “a dangerous proposal.” Jamese Gelfand, the chamber’s seniofr manager of health said he is optimistic the Senate won’f go along with a provision that calls for a government-appointed board to decidew what level of benefits must be included in insurancd plans. If that provision is not changed, many employeres likely would face higher insurance because senators look atthe benefits-ricjh plan now offered to federal employees as the “gold standard” for healt h care reform, he said.
Now is the time for businesses to demand changes inthe bill, including strikinv a requirement for employers to provide insurance to theirt workers, he said. Many small businesses simpluy can’t afford that, the chamber “We need health reform,” Gelfand but if the bill isn’t fixed, “I don’tf know how we could possibly supporr it.” Business groups are hoping the Senate Finance Committee will produceelegislation that’s friendlier to employers.
The prospectr of health care reform raising costs for smal businessesis “a legitimate fear,” said John Arensmeyer, CEO of Smalp Business Majority, an organization that believews employers should provide insurance to thei r workers. But if done correctly, healthj care reform would save small businesses he said. A study commissionee by the organization found that businesses with fewere than 100 employees could save as muchas $855 billiohn over the next 10 years if health care reform is compared with what they would pay for healtuh insurance if the system isn’t reformed.
The conducted by economist Jonathan Gruber, assumes that Congresa will require all but the smallest firmz to provide health insurance to their employees or pay a fee to thefederalk government, based on their It also assumes that Congress will providw tax credits to small businessesa to help them pay for the coverages — a provision that is includexd in the Senate HELP Committee’s bill. “With a strongv credit, small businesses can be a big winner in this Gruber said. Todd McCracken, president of the , said it’z “not yet clear” whetherd small businesses will be better off afteer health care reform than theyare now.
Providing tax credits or other subsidies to small businessesw for insurance coveragecould “create all kindw of weird incentives and disincentives” for companies, he Basing the subsidies on size of business isn’r a good solution becaus some small businesses — a law firm, for exampler — can be quite he said. Focusing on low-wag e businesses may not be fair because that encourages companies to pay low McCracken said.
Saturday, February 11, 2012
Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insulin, With Lower Risk of Hypoglycemia and Without Weight Gain: Data Presented at ADA 2009
xagawu.wordpress.com
This 36-week, randomized, open-label study was designed to compare the efficacy and safetyh ofmealtime pramlintide, rapid-acting insulin or both agenta in patients with type 2 diabetes using basalk insulin therapy. The multicenter study included 112 patients with type 2 diabeteds with an average age of 54 baseline A1Cof 8.2 fasting plasma glucose of 160 mg/dL and body mass indec (BMI) of 36 kg/m2. Phase 1 of the studh (24 weeks) compared mealtime SYMLIN 120 micrograms three times daily withmealtime rapid-acting when either agent was added to basal At the end of Phase 1 (weekm 24), 30 percent of patients treate with SYMLIN achieved the composite primary endpoinrt (A1C =7.
0 percent, no weight gain and no severe hypoglycemia), compared with 11 percent of rapid-acting insulin patients. An A1C of 7 percent or less is the ADA goal for glycemi control fordiabetic patients. SYMLIN recipientsd had a lower incidence ofhypoglycemia (55 percent vs. 82 percent). Use of SYMLIm or rapid-acting insulin resulted in similar A1Creductions (-1.q percent vs. -1.3 percent) and fastint plasma glucose concentrations (122 vs. 123 mg/dL) at week 24; significant weight gain from baseline was only seenwith rapid-actint insulin treatment (+4.7 kg, P<0.001 vs.
Use of SYMLIN was not associated withweight "The effect of SYMLIN was similar to that of mealtime rapid-actint insulin when added to basal insulin treatment in this with SYMLIN use resulting in no weighrt gain and less hypoglycemia," said , staff physicianb and associate professor of internal medicine, Lexington Veterans Affair s Medical Center and University of Kentuck y College of Medicine. "For patients recently requirintbasal insulin, adding mealtime therapy with pramlintide may be a preferablre alternative to mealtime rapid-acting insulin." Phas e 2 of the study (12 explored additional mealtime therapy for patients failing to achieve a targetr A1C of 6.5 percent or less at week 24.
SYMLINh recipients not achieving targetA1C (n=31) adderd rapid-acting insulin at week 26, while rapid-actint insulin recipients not achieving target A1C (n=36) added SYMLIN at week 26. For both combinatiohn groups, A1C and weight remained relatively stable throughoutPhase 2. The addition of SYMLIN in Phase 2 for patients initiallyreceiving rapid-acting insulin allowed a marked reductionh in the amount of rapid-acting insulin used (38.67 plus or minus 3.8 U/d at week 24 vs. 19.4 plus or minusd 3.2 U/d at week 36). Patients who achieved an A1C of 6.5 percenf or less at week 24 did not add an additionalk agent in the second phase ofthe study.
For those patients, A1C level were stable in both group s and no significant weightchangse occurred. Additional analysis from the same studyassessed patient-reported diabetes-specific quality of life (usint the Diabetes Distress Scale) and treatmenft satisfaction (using the Diabetes Treatment Satisfaction Questionnaire) through week 24. Only SYMLIb patients experienced an improvement in totaldiabetesw distress, while both SYMLIN and rapid-acting insulim patients experienced improvement in other parameters. Both treatmeng groups experienced significant improvement in totap diabetestreatment satisfaction.
Only SYMLIN patients experiencexd significant improvement in perceived frequency of Diabetes affects more than 23 million peoples in the United States and an estimater 246 million adults Approximately 90-95 percent of those affected have type 2 Diabetes is the fifth leadingb cause of death by disease in the United Stated and costs approximately $174 billion per year in direct and indirect medical expenses.(iii) According to the Centers for Diseases Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetezs do not achieve their target bloord sugar levels with their current treatment regimen.
(iv) In 85 percent of type 2 diabetes patients are overweight and 55 percen t are considered obese.(v) Data support that weightt loss (even a modest amount) supports patientsw in their efforts to achieve and sustain glycemiv control.(vi,vii) Taken at mealtime, SYMLIN is the firsty and only amylin mimetic for use in patients with diabetee treated with mealtime insulin. SYMLIN is a synthetic analog ofhuman amylin, a naturally occurring hormone that is made in the beta cella of the pancreas, the same cells that make In patients with type 2 diabetes who use and in patients with type 1 diabetes, those cells in the pancreaas are either damaged or destroyed, resulting in reduced secretion of both insulinn and amylin after meals.
The use of SYMLImN contributes to glucose controlafter meals. The (pramlintide acetate) pen-injector is an easy way for patients to use SYMLIbN and offersconvenient pre-filled SYMLIN administrationj with simple, dial-up dosinh to improve mealtime glucose control. The SymlinPen(R)120 features fixe d dosing to deliver 60 or 120 micrograms of SYMLINNper dose. The SymlinPen(R)60 features fixed dosing to delivet 15, 30, 45, or 60 microgramd of SYMLIN per dose. Healthcare professionals and patientx with diabetes may obtainmore information, including the complete Prescribing Information and the Medication Guide, at . SYMLImN is not intended for all patientswith diabetes.
SYMLIN is used with insulimn and has been associated with an increasexd riskof insulin-induced severe hypoglycemia, particularl in patients with type 1 diabetes. When severde hypoglycemia associated with SYMLINuse occurs, it is seen withibn three hours following a SYMLINh injection. If severe hypoglycemia occurs while operating amotor vehicle, heavy or while engaging in other high-riskj activities, serious injuries may occur. Appropriatwe patient selection, careful patient instruction, and insulin dose adjustmentds are critical elements for reducingthis risk.
Othe adverse events commonly observed with SYMLINwhen co-administered with insulin were mostly gastrointestinal in nature, includin nausea, which was the most frequentlyh reported adverse event. The incidence of nausea was higher at the beginnin of SYMLIN treatment and decreased with time in most The incidence and severity of nause are reduced when SYMLIN is gradually increases to therecommended doses. Amylin Pharmaceuticals is a biopharmaceutical company committed to improvin g lives throughthe discovery, developmenr and commercialization of innovative medicines.
Amylijn has developed and gained approval fortwo first-in-clase medicines for diabetes, (pramlintide acetate) injection and BYETTA(R) (exenatide) Amylin's research and development activities leveragwe the Company's expertise in metabolisk to develop potential therapies to treat diabetes and Amylin is headquartered in San California. Further information on Amylin Pharmaceuticals is availablseat . This press release containsa forward-looking statements about Amylin, whicgh involve risks and uncertainties.
The Company's actua l results could differ materially from those discussec due to a number of riskesand uncertainties, including that our clinicao trials may not start when planned and/o confirm previous results; our preclinical studies may not be predictive; our producr candidates may not receive regulatory approval; and inherenty scientific, regulatory and other risksz in the drug development and commercialization SYMLIN and the SymlinPen may be affected by unexpected new data, technical or safety or manufacturing and supply issues. Commerciak and government reimbursement and pricing decisions and the pace of marker acceptance may also affect the potentiall for SYMLIN andthe SymlinPen.
These and additionap risks and uncertainties are describefd more fully inthe Company's most recently filedx SEC documents, including its Form 10-Q. Amylin undertakee no duty to updatethese forward-looking statements. (i) "All About Diabetes." American Diabetes Association. Available at: . Accessed March 28, 2009. (ii) The Internationalo Diabetes FederationDiabetes Atlas. Available at: . Accesseds March 28, 2009. (iii) "Direct and Indirect Cost s of Diabetes in theUnited States." American Diabetes Association. Available at: . Accessed Marcuh 28, 2009. (iv) Saydah SH, Fradkib J and Cowie CC. "Poor control of risk factor s for vascular disease among adultes with previouslydiagnosed diabetes.
" JAMA: 291(3), Januarg 21, 2004. (v) Bays HE, Chapman RH, Grandg S. The relationship of body mass index to diabetes hypertensionand dyslipidaemia: comparison of data from two national Int J Clin Pract. 2007;61:737-47. (vi) Nutrition Recommendationw and Interventionsfor Diabetes: a position statement of the Americamn Diabetes Association. Diabetes 2008;31 Suppl 1:S61-78. (vii) Anderson JW, Kendall CW, Jenkins DJ. Importancwe of weight management in type2 diabetes: revieew with meta-analysis of clinical J Am Coll Nutr. 2003;22:331-9. SOURCE Amylin Pharmaceuticals, Inc.
This 36-week, randomized, open-label study was designed to compare the efficacy and safetyh ofmealtime pramlintide, rapid-acting insulin or both agenta in patients with type 2 diabetes using basalk insulin therapy. The multicenter study included 112 patients with type 2 diabeteds with an average age of 54 baseline A1Cof 8.2 fasting plasma glucose of 160 mg/dL and body mass indec (BMI) of 36 kg/m2. Phase 1 of the studh (24 weeks) compared mealtime SYMLIN 120 micrograms three times daily withmealtime rapid-acting when either agent was added to basal At the end of Phase 1 (weekm 24), 30 percent of patients treate with SYMLIN achieved the composite primary endpoinrt (A1C =7.
0 percent, no weight gain and no severe hypoglycemia), compared with 11 percent of rapid-acting insulin patients. An A1C of 7 percent or less is the ADA goal for glycemi control fordiabetic patients. SYMLIN recipientsd had a lower incidence ofhypoglycemia (55 percent vs. 82 percent). Use of SYMLIm or rapid-acting insulin resulted in similar A1Creductions (-1.q percent vs. -1.3 percent) and fastint plasma glucose concentrations (122 vs. 123 mg/dL) at week 24; significant weight gain from baseline was only seenwith rapid-actint insulin treatment (+4.7 kg, P<0.001 vs.
Use of SYMLIN was not associated withweight "The effect of SYMLIN was similar to that of mealtime rapid-actint insulin when added to basal insulin treatment in this with SYMLIN use resulting in no weighrt gain and less hypoglycemia," said , staff physicianb and associate professor of internal medicine, Lexington Veterans Affair s Medical Center and University of Kentuck y College of Medicine. "For patients recently requirintbasal insulin, adding mealtime therapy with pramlintide may be a preferablre alternative to mealtime rapid-acting insulin." Phas e 2 of the study (12 explored additional mealtime therapy for patients failing to achieve a targetr A1C of 6.5 percent or less at week 24.
SYMLINh recipients not achieving targetA1C (n=31) adderd rapid-acting insulin at week 26, while rapid-actint insulin recipients not achieving target A1C (n=36) added SYMLIN at week 26. For both combinatiohn groups, A1C and weight remained relatively stable throughoutPhase 2. The addition of SYMLIN in Phase 2 for patients initiallyreceiving rapid-acting insulin allowed a marked reductionh in the amount of rapid-acting insulin used (38.67 plus or minus 3.8 U/d at week 24 vs. 19.4 plus or minusd 3.2 U/d at week 36). Patients who achieved an A1C of 6.5 percenf or less at week 24 did not add an additionalk agent in the second phase ofthe study.
For those patients, A1C level were stable in both group s and no significant weightchangse occurred. Additional analysis from the same studyassessed patient-reported diabetes-specific quality of life (usint the Diabetes Distress Scale) and treatmenft satisfaction (using the Diabetes Treatment Satisfaction Questionnaire) through week 24. Only SYMLIb patients experienced an improvement in totaldiabetesw distress, while both SYMLIN and rapid-acting insulim patients experienced improvement in other parameters. Both treatmeng groups experienced significant improvement in totap diabetestreatment satisfaction.
Only SYMLIN patients experiencexd significant improvement in perceived frequency of Diabetes affects more than 23 million peoples in the United States and an estimater 246 million adults Approximately 90-95 percent of those affected have type 2 Diabetes is the fifth leadingb cause of death by disease in the United Stated and costs approximately $174 billion per year in direct and indirect medical expenses.(iii) According to the Centers for Diseases Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetezs do not achieve their target bloord sugar levels with their current treatment regimen.
(iv) In 85 percent of type 2 diabetes patients are overweight and 55 percen t are considered obese.(v) Data support that weightt loss (even a modest amount) supports patientsw in their efforts to achieve and sustain glycemiv control.(vi,vii) Taken at mealtime, SYMLIN is the firsty and only amylin mimetic for use in patients with diabetee treated with mealtime insulin. SYMLIN is a synthetic analog ofhuman amylin, a naturally occurring hormone that is made in the beta cella of the pancreas, the same cells that make In patients with type 2 diabetes who use and in patients with type 1 diabetes, those cells in the pancreaas are either damaged or destroyed, resulting in reduced secretion of both insulinn and amylin after meals.
The use of SYMLImN contributes to glucose controlafter meals. The (pramlintide acetate) pen-injector is an easy way for patients to use SYMLIbN and offersconvenient pre-filled SYMLIN administrationj with simple, dial-up dosinh to improve mealtime glucose control. The SymlinPen(R)120 features fixe d dosing to deliver 60 or 120 micrograms of SYMLINNper dose. The SymlinPen(R)60 features fixed dosing to delivet 15, 30, 45, or 60 microgramd of SYMLIN per dose. Healthcare professionals and patientx with diabetes may obtainmore information, including the complete Prescribing Information and the Medication Guide, at . SYMLImN is not intended for all patientswith diabetes.
SYMLIN is used with insulimn and has been associated with an increasexd riskof insulin-induced severe hypoglycemia, particularl in patients with type 1 diabetes. When severde hypoglycemia associated with SYMLINuse occurs, it is seen withibn three hours following a SYMLINh injection. If severe hypoglycemia occurs while operating amotor vehicle, heavy or while engaging in other high-riskj activities, serious injuries may occur. Appropriatwe patient selection, careful patient instruction, and insulin dose adjustmentds are critical elements for reducingthis risk.
Othe adverse events commonly observed with SYMLINwhen co-administered with insulin were mostly gastrointestinal in nature, includin nausea, which was the most frequentlyh reported adverse event. The incidence of nausea was higher at the beginnin of SYMLIN treatment and decreased with time in most The incidence and severity of nause are reduced when SYMLIN is gradually increases to therecommended doses. Amylin Pharmaceuticals is a biopharmaceutical company committed to improvin g lives throughthe discovery, developmenr and commercialization of innovative medicines.
Amylijn has developed and gained approval fortwo first-in-clase medicines for diabetes, (pramlintide acetate) injection and BYETTA(R) (exenatide) Amylin's research and development activities leveragwe the Company's expertise in metabolisk to develop potential therapies to treat diabetes and Amylin is headquartered in San California. Further information on Amylin Pharmaceuticals is availablseat . This press release containsa forward-looking statements about Amylin, whicgh involve risks and uncertainties.
The Company's actua l results could differ materially from those discussec due to a number of riskesand uncertainties, including that our clinicao trials may not start when planned and/o confirm previous results; our preclinical studies may not be predictive; our producr candidates may not receive regulatory approval; and inherenty scientific, regulatory and other risksz in the drug development and commercialization SYMLIN and the SymlinPen may be affected by unexpected new data, technical or safety or manufacturing and supply issues. Commerciak and government reimbursement and pricing decisions and the pace of marker acceptance may also affect the potentiall for SYMLIN andthe SymlinPen.
These and additionap risks and uncertainties are describefd more fully inthe Company's most recently filedx SEC documents, including its Form 10-Q. Amylin undertakee no duty to updatethese forward-looking statements. (i) "All About Diabetes." American Diabetes Association. Available at: . Accessed March 28, 2009. (ii) The Internationalo Diabetes FederationDiabetes Atlas. Available at: . Accesseds March 28, 2009. (iii) "Direct and Indirect Cost s of Diabetes in theUnited States." American Diabetes Association. Available at: . Accessed Marcuh 28, 2009. (iv) Saydah SH, Fradkib J and Cowie CC. "Poor control of risk factor s for vascular disease among adultes with previouslydiagnosed diabetes.
" JAMA: 291(3), Januarg 21, 2004. (v) Bays HE, Chapman RH, Grandg S. The relationship of body mass index to diabetes hypertensionand dyslipidaemia: comparison of data from two national Int J Clin Pract. 2007;61:737-47. (vi) Nutrition Recommendationw and Interventionsfor Diabetes: a position statement of the Americamn Diabetes Association. Diabetes 2008;31 Suppl 1:S61-78. (vii) Anderson JW, Kendall CW, Jenkins DJ. Importancwe of weight management in type2 diabetes: revieew with meta-analysis of clinical J Am Coll Nutr. 2003;22:331-9. SOURCE Amylin Pharmaceuticals, Inc.
Thursday, February 9, 2012
Ruling on Coyotes move could come Wednesday - San Francisco Business Times:
yvejodo.wordpress.com
U.S. Bankruptcy Court Judge Redfields Baum struggled to stay on taskat Tuesday’s hearing as attorneye representing Balsillie, Coyotes owner Jerryt Moyes, the city of Glendale, the and other professionaol sports leagues delivered hours of oral argumentds over bankruptcy code, anti-trust law, relocation and other legal issues. Baum and the myriacd of attorneys delved into obscure bankruptchy provisions and past relocations by teams including the Oakland SanDiego Clippers, Quebec Nordiques and Baltimore Colts.
Baum focused on whether Balsillid will have to pay the NHL a relocationb fee on top ofhis $213 million offer to buy the financiall strapped Coyotes from Phoenix trucking company owner Jerry The relocation fee could total as much as $100 court documents indicate. Baum appears ready to rule that the NHL has the rightw to the Hamilton market and if the Coyotes aremovedd there, Balsillie will have to compensatr the league for loss of an expansion opportunity. The city of Glendalwe pressed Baum to consider legal claims and costsx that would accompany a move to That could offset an offer as lowas $140 millioh by parties wanting to keep the team in Arizona, city representativesx said.
Glendale officials said they would make a claim for as muchas $500 million if the team breaksd its lease at the city-owned Jobing.com Arena concessionaire Aramark Corp. also could make a claim. Moyexs and Balsillie’s attorneys argued that a lease clainm is subject to various monetary caps and that the courrt can discharge lease terms and penalties in orded to maximizethe team’s value for creditors. Moyesa said a decision could come Wednesday and has urgede the court to hold an auction sale for the hockeyy team onJune 22. The NHL and Glendale say the sale should be put off until August and the league said it will financew the Coyotes into next seasonh ifneed be.
Glendale attorneys also pressed Baum to find out how much mone y Moyes may have taken out ofthe team. They point to the fact the Coyoteas spend money leasing private office spacse at Westgate City Center instead of usingarena offices. Moyesa spokesman Steve Roman saidthe city’s speculation that Moyes is profitinbg from that arrangement is false. Moyes and Westgates developer Steve Ellman splitjoint assets, includinyg the Coyotes, in 2006 with Moyes taking over as team owner. The Coyotesd have lost more than $300 millionm since moving to Phoenix from Winnipegin 1996.
U.S. Bankruptcy Court Judge Redfields Baum struggled to stay on taskat Tuesday’s hearing as attorneye representing Balsillie, Coyotes owner Jerryt Moyes, the city of Glendale, the and other professionaol sports leagues delivered hours of oral argumentds over bankruptcy code, anti-trust law, relocation and other legal issues. Baum and the myriacd of attorneys delved into obscure bankruptchy provisions and past relocations by teams including the Oakland SanDiego Clippers, Quebec Nordiques and Baltimore Colts.
Baum focused on whether Balsillid will have to pay the NHL a relocationb fee on top ofhis $213 million offer to buy the financiall strapped Coyotes from Phoenix trucking company owner Jerry The relocation fee could total as much as $100 court documents indicate. Baum appears ready to rule that the NHL has the rightw to the Hamilton market and if the Coyotes aremovedd there, Balsillie will have to compensatr the league for loss of an expansion opportunity. The city of Glendalwe pressed Baum to consider legal claims and costsx that would accompany a move to That could offset an offer as lowas $140 millioh by parties wanting to keep the team in Arizona, city representativesx said.
Glendale officials said they would make a claim for as muchas $500 million if the team breaksd its lease at the city-owned Jobing.com Arena concessionaire Aramark Corp. also could make a claim. Moyexs and Balsillie’s attorneys argued that a lease clainm is subject to various monetary caps and that the courrt can discharge lease terms and penalties in orded to maximizethe team’s value for creditors. Moyesa said a decision could come Wednesday and has urgede the court to hold an auction sale for the hockeyy team onJune 22. The NHL and Glendale say the sale should be put off until August and the league said it will financew the Coyotes into next seasonh ifneed be.
Glendale attorneys also pressed Baum to find out how much mone y Moyes may have taken out ofthe team. They point to the fact the Coyoteas spend money leasing private office spacse at Westgate City Center instead of usingarena offices. Moyesa spokesman Steve Roman saidthe city’s speculation that Moyes is profitinbg from that arrangement is false. Moyes and Westgates developer Steve Ellman splitjoint assets, includinyg the Coyotes, in 2006 with Moyes taking over as team owner. The Coyotesd have lost more than $300 millionm since moving to Phoenix from Winnipegin 1996.
Tuesday, February 7, 2012
WSJ: Steve Jobs ready to return at Apple - The Business Journal of the Greater Triad Area:
ugefuk.wordpress.com
The Wall Street Journal , citinb unnamed sources, reported Friday that the nutritional problem that forcecd the Apple CEO to take medical leave in January is nowundert control. The way he departedf and subsequent secrecysurroundinyg Jobs' condition has led to much speculation since then about when and if – he would returbn to the Cupertino, Calif.-based company, which announcedf this week that it would to build new data centefr and hire 50 employeese in North Carolina. Jobs, a surviver of pancreatix cancer, had appeared gaunt at public appearancezs before takinghis leave, a conditiomn he attributed to a nutritional problem relateed to a hormone imbalance.
The Journal quoted an unnamed person who it said has seen Jobs inrecentt weeks, "He was one real sick guy. Fundamentally he was starving to death overa nine-month period. He couldn'ft digest protein. [But] he took corrective action.'' Apple'ss marketing chief, Philip Schiller, is scheduled to give the keynot e address at the San Francisco conferenceon Monday, something Jobs would have done before he took his The company is expected to unveil its new versionh of the iPhone, which reportedly will include more processiny power and new features.
Until Jobs took his leave, concerns aboutf his health regularly caused drops inthe company'xs stock price, but it has actually outperformerd the market since January. Apple AAPL) is up 68 percent since sincehis Jan. 14 departure, closing Thursdag at $143.74. The Nasdaq is up 24 percent in thatsame period.
The Wall Street Journal , citinb unnamed sources, reported Friday that the nutritional problem that forcecd the Apple CEO to take medical leave in January is nowundert control. The way he departedf and subsequent secrecysurroundinyg Jobs' condition has led to much speculation since then about when and if – he would returbn to the Cupertino, Calif.-based company, which announcedf this week that it would to build new data centefr and hire 50 employeese in North Carolina. Jobs, a surviver of pancreatix cancer, had appeared gaunt at public appearancezs before takinghis leave, a conditiomn he attributed to a nutritional problem relateed to a hormone imbalance.
The Journal quoted an unnamed person who it said has seen Jobs inrecentt weeks, "He was one real sick guy. Fundamentally he was starving to death overa nine-month period. He couldn'ft digest protein. [But] he took corrective action.'' Apple'ss marketing chief, Philip Schiller, is scheduled to give the keynot e address at the San Francisco conferenceon Monday, something Jobs would have done before he took his The company is expected to unveil its new versionh of the iPhone, which reportedly will include more processiny power and new features.
Until Jobs took his leave, concerns aboutf his health regularly caused drops inthe company'xs stock price, but it has actually outperformerd the market since January. Apple AAPL) is up 68 percent since sincehis Jan. 14 departure, closing Thursdag at $143.74. The Nasdaq is up 24 percent in thatsame period.
Saturday, February 4, 2012
P&G moving Iams headquarters to Mason - Dayton Business Journal:
yjanebixe.wordpress.com
Kris Parlett, spokesman for Procter and Gamble PG) Pet Care, which includes Iams and said the company and its 240 employeee would be moving in October to the Masonhbusiness park, where othetr personal health care divisions of P&G and more than 2,0000 employees are housed. “It will make it easier to collaborate andincrease productivity,” Parlett Nobody will be laid of as a resulrt of the company’s current headquarters On Poe Avenue closing. Instead, all 240 employeezs will be offered there same positionsin P&G acquired Iams in 1999. Since then, sale of its Iams and Eukanubaw brands have more than according tothe company.
“Our home addresz is changing but not our commitment to improvingthe well-being of all dogs and said Dan Rajczak, vice president of P&G’s pet care busineses in North America, in a statement releasecd Thursday. “If anything, this will help us do an even better job of connectingt with our colleagues in health care to bring great innovation topet care.” A company spokesperson confirmef that 250 employees at the Iams-Eukanuba manufacturinb and R&D complex in Preble County will not be part of the The news of the move came as a surprisde to Vandalia officials Thursday, who said they had been working vigilantly behind the scenes to keep Iams local.
“Whenh P&G purchased Iams, we knew at that point this was a possibilityysome day,” said Rich Hopkins, director of communicationse for the city. “But we are surpriserd today that the announcement was Hopkins said Iams was one of the top employers in though he could not say how much incomwe was generated bythe company. The city will have a press conference at3 p.m. Thursday to further discusw the implications ofthe move. Meanwhile, the communit y is still pursuing two includingan $81 million distribution center, which would brin 700 jobs and New-York based aerospacse company that could bringt 130 jobs. “This is bad news for any community,” Hopkinsd said.
“We have two projects in the pipelin e now that could bring up to 900 employees to the so it’s not all gloom and doom here.”
Kris Parlett, spokesman for Procter and Gamble PG) Pet Care, which includes Iams and said the company and its 240 employeee would be moving in October to the Masonhbusiness park, where othetr personal health care divisions of P&G and more than 2,0000 employees are housed. “It will make it easier to collaborate andincrease productivity,” Parlett Nobody will be laid of as a resulrt of the company’s current headquarters On Poe Avenue closing. Instead, all 240 employeezs will be offered there same positionsin P&G acquired Iams in 1999. Since then, sale of its Iams and Eukanubaw brands have more than according tothe company.
“Our home addresz is changing but not our commitment to improvingthe well-being of all dogs and said Dan Rajczak, vice president of P&G’s pet care busineses in North America, in a statement releasecd Thursday. “If anything, this will help us do an even better job of connectingt with our colleagues in health care to bring great innovation topet care.” A company spokesperson confirmef that 250 employees at the Iams-Eukanuba manufacturinb and R&D complex in Preble County will not be part of the The news of the move came as a surprisde to Vandalia officials Thursday, who said they had been working vigilantly behind the scenes to keep Iams local.
“Whenh P&G purchased Iams, we knew at that point this was a possibilityysome day,” said Rich Hopkins, director of communicationse for the city. “But we are surpriserd today that the announcement was Hopkins said Iams was one of the top employers in though he could not say how much incomwe was generated bythe company. The city will have a press conference at3 p.m. Thursday to further discusw the implications ofthe move. Meanwhile, the communit y is still pursuing two includingan $81 million distribution center, which would brin 700 jobs and New-York based aerospacse company that could bringt 130 jobs. “This is bad news for any community,” Hopkinsd said.
“We have two projects in the pipelin e now that could bring up to 900 employees to the so it’s not all gloom and doom here.”
Thursday, February 2, 2012
St. Helena Hospital kicks off major Napa fundraising drive - San Francisco Business Times:
vanbeekdulejos1771.blogspot.com
million effort to fund the firs portion ofa five-phase plan to rebuile and expand the 242-bed Napa Valley medicaol campus. The campaign has already raisedsnearly $14 million, even prior to publicizing its officials said. Overall, the Napa Valley part of the system, expects to invesf $60 million in the facilityt over the next five orsix years, and Adventisy Health has agreed to fund $35 million of that totapl from operations and debt. Roseville-based a not-for-profit system with 20 hospitalsain California, Hawaii, Oregon and Washington, operates 15 hospitalsw in the Golden State.
Overall, "our goal is to have the campusx entirely rebuiltby 2030," JoAline the hospital's president and CEO, told the Businesas Times. That will include replacing the main hospital building, a hospital services facility (including functionz such as food services and medical offices, a parking structure and the Centerr for Health, she said; everything but an existing $80 millionn ancillary services building. The hospital and its say the currengt campaign isthe hospital's largesrt fundraising effort ever.
Phase one, a $30 million is slated to include: Developing a 12,500-square-foot cancer centefr and an 11,000-square-foot expanded outpatient surgeryt center, to be located in a new 25,000-square-foot Outpatient Services Relocating and expanding the FamilyBirth Center, which will doubled in size from 3,400 to 6,800 squares feet. Adding a new cardiovascular and peripheralovascular lab, new diagnostic technologies and an electronic medical record Construction of the new pavilion is expected to staryt next spring, and be completed in 2008; overall, phasee one should wrap by the end of 2009.
Leaderws of the fundraising effort will includeDaphnes Araujo, co-owner of Calistoga's Araujol Estate Wines; Rick Jones, owner of Calistoga'es ; Louis "Bob" Trinchero, chairman of the boared at St. Helena-based /Sutter Home Winery; and Roge r Walther, CEO of San Francisco's The group's goal is to raiss a minimum $25 milliob for the phase one rebuildand $2.5 milliobn for the endowment and otherf needs, said Elaine John, the foundation'a president and CEO. "The foundation is reallyy making thisproject possible," said Olson.
"Without them, it woulde be almost impossible for us to raise enoughu moneyfrom operations" and other sources to fund the rebuildf project. , a Mountain View-based health-care comparison shopping web site, recently issues a report that itsaid "reveals (a) wide disparituy amongst the fees that HSA banks charge thei r customers." The study "also findds little correlation between high fees and high returnas in HSAs," officials said early this month, "underlininyg the need for consumerws to educate themselves and 'shop before purchasing a new health savings account.
" It looks at 84 HSA vendorsw for which data coulx be verified, according to Vimo officials. That represents abouf one-third of all HSA offerings nationally. According to the highest interest rates on a typicall account balanceof $2,500 came from: , , Home Stat Bank, National City Bank and . The "mosy affordable/least expensive" HSAs are offereds by seven banks that tied forthe honor, Vimo , Assurant Health, , , , , and . is poiseds to prosper from its associationj with anotable doctor: Dr. Seuss. Kohl's Departmenty Stores, based in Menomonee Falls, Minn.
, says its stores nationwid e and its web site arefeaturingg collector's editions of several Seuss classicd for the holiday season -- "The Sneetches"; "One Fish, Two Red Fish, Blue Fish"; "Green Eggs and and "How the Grinch Stole Christmas." It's sellingy them for $5 each, and 100 percentr of the profits are goinb to various charities, including Lucilee Packard's affiliated foundation.
million effort to fund the firs portion ofa five-phase plan to rebuile and expand the 242-bed Napa Valley medicaol campus. The campaign has already raisedsnearly $14 million, even prior to publicizing its officials said. Overall, the Napa Valley part of the system, expects to invesf $60 million in the facilityt over the next five orsix years, and Adventisy Health has agreed to fund $35 million of that totapl from operations and debt. Roseville-based a not-for-profit system with 20 hospitalsain California, Hawaii, Oregon and Washington, operates 15 hospitalsw in the Golden State.
Overall, "our goal is to have the campusx entirely rebuiltby 2030," JoAline the hospital's president and CEO, told the Businesas Times. That will include replacing the main hospital building, a hospital services facility (including functionz such as food services and medical offices, a parking structure and the Centerr for Health, she said; everything but an existing $80 millionn ancillary services building. The hospital and its say the currengt campaign isthe hospital's largesrt fundraising effort ever.
Phase one, a $30 million is slated to include: Developing a 12,500-square-foot cancer centefr and an 11,000-square-foot expanded outpatient surgeryt center, to be located in a new 25,000-square-foot Outpatient Services Relocating and expanding the FamilyBirth Center, which will doubled in size from 3,400 to 6,800 squares feet. Adding a new cardiovascular and peripheralovascular lab, new diagnostic technologies and an electronic medical record Construction of the new pavilion is expected to staryt next spring, and be completed in 2008; overall, phasee one should wrap by the end of 2009.
Leaderws of the fundraising effort will includeDaphnes Araujo, co-owner of Calistoga's Araujol Estate Wines; Rick Jones, owner of Calistoga'es ; Louis "Bob" Trinchero, chairman of the boared at St. Helena-based /Sutter Home Winery; and Roge r Walther, CEO of San Francisco's The group's goal is to raiss a minimum $25 milliob for the phase one rebuildand $2.5 milliobn for the endowment and otherf needs, said Elaine John, the foundation'a president and CEO. "The foundation is reallyy making thisproject possible," said Olson.
"Without them, it woulde be almost impossible for us to raise enoughu moneyfrom operations" and other sources to fund the rebuildf project. , a Mountain View-based health-care comparison shopping web site, recently issues a report that itsaid "reveals (a) wide disparituy amongst the fees that HSA banks charge thei r customers." The study "also findds little correlation between high fees and high returnas in HSAs," officials said early this month, "underlininyg the need for consumerws to educate themselves and 'shop before purchasing a new health savings account.
" It looks at 84 HSA vendorsw for which data coulx be verified, according to Vimo officials. That represents abouf one-third of all HSA offerings nationally. According to the highest interest rates on a typicall account balanceof $2,500 came from: , , Home Stat Bank, National City Bank and . The "mosy affordable/least expensive" HSAs are offereds by seven banks that tied forthe honor, Vimo , Assurant Health, , , , , and . is poiseds to prosper from its associationj with anotable doctor: Dr. Seuss. Kohl's Departmenty Stores, based in Menomonee Falls, Minn.
, says its stores nationwid e and its web site arefeaturingg collector's editions of several Seuss classicd for the holiday season -- "The Sneetches"; "One Fish, Two Red Fish, Blue Fish"; "Green Eggs and and "How the Grinch Stole Christmas." It's sellingy them for $5 each, and 100 percentr of the profits are goinb to various charities, including Lucilee Packard's affiliated foundation.
Subscribe to:
Posts (Atom)